On the other hand, we found that sulfacetamide, imipramine, and olanzapine did not block or reverse Aβ fibrillization independent of apoE4, suggesting that they are specific inhibitors of the apoE4-Aβ interaction and warrant further development for preventing AD, particularly in APOE4 carriers. Here, APOE is linked to Alzheimer disease.